Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
226,664,950
-
Total 13F shares
-
22,130,549
-
Share change
-
+7,337,421
-
Total reported value
-
$18,494,153
-
Put/Call ratio
-
118%
-
Price per share
-
$0.84
-
Number of holders
-
57
-
Value change
-
+$6,146,126
-
Number of buys
-
41
-
Number of sells
-
11
Institutional Holders of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) as of Q4 2024
As of 31 Dec 2024,
Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,130,549 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, UBS Group AG, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and JPMORGAN CHASE & CO.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.